BioSpace News Archive

Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has received notification from the U.S. Food and Drug Administration (FDA) confirming it has fulfilled all post-approval study requirements

Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the company will release first quarter 2021 financial results on Monday, May 10, 2021 after the close of market. Revance will host a corresponding conference call and a live webcast at 1:30 p.m. PT

OpRegen ® Clinical Data Continues to Demonstrate Improvements in Patients With Dry AMD With Geographic Atrophy Eighty-Three Percent of All Cohort 4 Patients Exhibited Stable or Improved BCVA Visual Acuity Declined in the Majority of Untreated Eyes

Resonant Inc. (NASDAQ: RESN), a provider of radio frequency (RF) filter solutions developed on a robust intellectual property platform, designed to connect People and Things, will release financial results for the first quarter ended March 31st, 2021 after market close on Wednesday, May 12th, 2021.

Align Technology, Inc. announced that it has entered into an accelerated stock repurchase agreement with Goldman Sachs & Co LLC, to repurchase $100 million of Align’s common stock to complete its $600 million stock repurchase program announced on May 23, 2018.

Transparency Market Research has published a new report on the varicose vein treatment market. According to the report, the global varicose vein treatment market was valued at ~US$ 1.5 Bn in 2018 and is projected to expand at a CAGR of ~5% from 2019 to 2027.

Gene editing or genome editing is the targeted insertion or modification of cells in living organism or cells and the method has come to occupy a crucial part of biomedical researches, constantly transforming various disciplines of life sciences.

Breast imaging refers to a subspecialty in the field of diagnostic radiology. It comprises an extensive range of various imaging procedures.

Medical device company Occlutech Holding AG, one of the world´s leading providers of minimally invasive structural heart disease devices, announces the election of four new members to the board

Amphastar Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration approved the Company’s Abbreviated New Drug Application for Morphine Sulfate injection 1mg/mL in the 30mL Pump-Jet® Prefilled Syringe System.